Mirati Therapeutics reported $119.15M in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agios Pharmaceuticals AGIO:US $ 48.4M 2.6M
Alnylam Pharmaceuticals ALNY:US $ 657.68M 51.72M
Amgen AMGN:US $ 12618M 268M
Astellas Pharma 4503:JP Y 740538M 53127M
AstraZeneca AZN:LN 21815M 925M
Bayer BAYN:GR € 33643M 2624M
Bluebird Bio BLUE:US $ 148.86M 5.97M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Eisai 4523:JP Y 301894M 11439M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Exelixis EXEL:US $ 304.52M 15.44M
Gilead Sciences GILD:US $ 9220M 662M
GlaxoSmithKline GSK:LN 37835M 13557M
IONIS PHARMACEUT IONS:US $ 267.81M 39.36M
Moderna Inc MRNA:US 6.81B 2.43B
Nektar Therapeutics NKTR:US $ 104.98M 0.3M
Novartis NOVN:VX SF 27646M 2161M
Puma Biotechnology PBYI:US $ 56.83M 17.95M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Seattle Genetics SGEN:US $ 608.52M 77.23M
Spectrum Pharmaceuticals SPPI:US $ 41.04M 1.83M
Takeda 4502:JP Y 2166942M 21212M
Ultragenyx Pharmaceutical RARE:US $ 220.64M 53.4M
YTE INCY:US $ 926.67M 40.51M